In Phase II-IV

PharmaNet offers all the clinical development services traditionally associated with conducting Phase II-IV programs. A key differentiating factor of PharmaNet is that in every program we conduct, PharmaNet provides an unrivaled combination of experienced project-management teams, senior management oversight, and an exclusive approach to building relationships with sponsors.

Quality Control/Assurance

Quality Assurance (QA) lies at the foundation of good clinical research.  That’s why PharmaNet takes pride in our excellent reputation in the field of QA as applied to our own clinical development services or to our comprehensive QA service offering to pharmaceutical and biotech companies.
 
Since objectivity is critical to fulfill the complex role of quality assurance professionals, PharmaNet ensures we conduct unbiased assessments by separating the roles of QA from the operational reporting structure. Our auditors offer this same impartiality for your studies and can enhance your compliance efforts.
 
Our QA team consists of nineteen senior auditors with expertise in Good Clinical Practice (GCP), Good Laboratory Practice (GLP), and Good Manufacturing Practice (GMP) with an average of twelve years industry experience. PharmaNet auditors are located throughout the United States, Canada, Argentina, United Kingdom, Germany, Russia, and Sweden. We have conducted audits in forty-five countries including the regions of the Americas, Eastern and Western Europe, Asia-Pacific, and Africa. What’s more our staff can conduct business in multiple languages.
 
PharmaNet Global Quality Assurance Services include:

 

Audit services for:

 Investigator sites
 Clinical and analytical laboratories
 Drug packaging and distributors
 Institutional Review Boards
 Phase I Units
 Suppliers/vendors
 Sites and laboratories in developing countries to assess readiness
 to conduct clinical trials

 

Validation services for:

 Computer systems
 Databases
 SOPs

 

Specific QA of study deliverables including:

 Protocols
 CRFs
 Clinical Study Reports
 Study Files
 Tables and Listings

 

 Regulatory inspection preparedness and response services

 SOP development
 Assist with FDA and MHRA mock regulatory inspections
 Training to prepare investigator sites for actual regulatory inspections
 Assist preparing responses to FDA 483s

 

 

For more information:

In the Americas
Martin Valania
Vice President, Quality Assurance
609 951 6690

In Rest of World
Alec Deighton
Senior Director, Quality Assurance and Compliance
44 1494 896 270


Martin F. Valania

Vice President, Corporate QA and Compliance

Mr. Valania has more than 15 years experience and is a Certified Quality Manager and Certified Quality Auditor through the American Society for Quality. Before joining PharmaNet, he was the director of quality systems at a major CRO and the associate director of manufacturing processes at DuPont.

PharmaNet Development Group, Inc.504 Carnegie Center, Princeton, NJ 08540Tel 609 951 6800Fax 609 514 0390